You are here

Study Evaluating ReFacto in Hemophilia A

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hemophilia A
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients who were or are enrolled in Study CTN 93-R833-0XX/C9741-28, and have been
treated with ReFacto® during this study are eligible for participation.

- The patient (or legal guardian) must be willing to give written informed consent
before any study-related procedures are performed.

- A blood sample will be collected from each patient for the purpose of this study and
will be analyzed at one or both of the designated central laboratories.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any condition which, in the investigator's opinion, places the patient at undue risk.

NCT00038909
Pfizer
Completed
Study Evaluating ReFacto in Hemophilia A

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Hemophilia A, Hemophilia B
NCT03938792
Males
12+
Years
Little Rock, Arkansas
Hemophilia A or B
NCT03363321
Males
12+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now